Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546207 · ClinicalTrials.gov registry record · NA
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
A NA study, sponsored by Vivek Reddy.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01546207 is a NA study that was terminated before completion, run by Vivek Reddy. The registered enrollment target is 4 participants.
The verdict
NCT01546207, a NA study, was terminated before completion, sponsored by Vivek Reddy.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The goal of this trial is to test the impact of a step-wise approach for catheter ablation of recurrent ventricular tachycardia, (irregular heart rhythms that originate in the bottom chambers of the heart), in patients with a previous heart attack for whom catheter ablation is clinically indicated.
Interventions
- PROCEDURE catheter-based ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01546207
The ClinicalTrials.gov registry entry for NCT01546207 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which catheter-based ablation is the first listed.
NCT01546207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01546207 about?
NCT01546207 is a clinical study titled "Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia". The goal of this trial is to test the impact of a step-wise approach for catheter ablation of recurrent ventricular tachycardia, (irregular heart rhythms that originate in the bottom chambers of the heart), in patients with a previous heart attack for whom catheter ablation is clinically indicated.
What is the current status of trial NCT01546207?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2011-09. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01546207?
The interventions under investigation include: catheter-based ablation (PROCEDURE).
Who is sponsoring clinical trial NCT01546207?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.